The clinical course of Crohn’s disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The clinical course of Crohn’s disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017. / Burisch, Johan; Lophaven, Søren; Langholz, Ebbe; Munkholm, Pia.

In: Alimentary Pharmacology and Therapeutics, Vol. 55, No. 1, 2022, p. 73-82.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Burisch, J, Lophaven, S, Langholz, E & Munkholm, P 2022, 'The clinical course of Crohn’s disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017', Alimentary Pharmacology and Therapeutics, vol. 55, no. 1, pp. 73-82. https://doi.org/10.1111/apt.16615

APA

Burisch, J., Lophaven, S., Langholz, E., & Munkholm, P. (2022). The clinical course of Crohn’s disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017. Alimentary Pharmacology and Therapeutics, 55(1), 73-82. https://doi.org/10.1111/apt.16615

Vancouver

Burisch J, Lophaven S, Langholz E, Munkholm P. The clinical course of Crohn’s disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017. Alimentary Pharmacology and Therapeutics. 2022;55(1):73-82. https://doi.org/10.1111/apt.16615

Author

Burisch, Johan ; Lophaven, Søren ; Langholz, Ebbe ; Munkholm, Pia. / The clinical course of Crohn’s disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017. In: Alimentary Pharmacology and Therapeutics. 2022 ; Vol. 55, No. 1. pp. 73-82.

Bibtex

@article{c1effac32a3542deaccf7d9bee8b4ca5,
title = "The clinical course of Crohn{\textquoteright}s disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017",
abstract = "Background: Few population-based studies have investigated the long-term prognosis of Crohn's disease (CD). Aim: To determine the long-term natural disease course of CD with regard to surgery, cancer and mortality in a population-based cohort followed for more than 50 years. Methods: All patients diagnosed with CD from 1962 to 1987 in Copenhagen County, Denmark were included in a population-based cohort. Information about surgeries, cancers and mortality was collected from patient files from 1962 to 1987 and from the Danish National Patient Registry, Cancer Registry, and from the Register of Causes of Death, 1987-2017. Patients were matched with individuals from the general population. Results: A total of 373 patients were followed for a median of 33 years (range: 0-56 years). The cumulative probability of surgery 10, 20, 30, 40 and 50 years after diagnosis was 62% (CI 95%: 57%-67%), 71% (CI 95%: 66%-75%), 72% (CI 95%: 67%-76%), 74% (CI 95%: 69%-79%) and 74% (CI 95%: 69%-79%), respectively. A total of 142 patients (54%) were operated upon at least twice: 69 (26%) needing two surgeries and 73 (28%) needing three or more. Patients with CD were found to be at increased risk of intestinal (small bowel, rectum and anus) and extra-intestinal (respiratory organs and skin) cancer. All-cause mortality among CD patients was higher than among controls (RR: 1.22, CI 95%: 1.04-1.43), whereas mortality due to gastrointestinal cancer was not. Conclusion: After 50 years of follow-up, 75% CD patients had undergone surgery, with most needing repeat surgery. The risk of intestinal and extra-intestinal cancers, as well as mortality, was higher among CD patients than the background population.",
author = "Johan Burisch and S{\o}ren Lophaven and Ebbe Langholz and Pia Munkholm",
note = "Publisher Copyright: {\textcopyright} 2021 John Wiley & Sons Ltd",
year = "2022",
doi = "10.1111/apt.16615",
language = "English",
volume = "55",
pages = "73--82",
journal = "Alimentary Pharmacology and Therapeutics, Supplement",
issn = "0953-0673",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - The clinical course of Crohn’s disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017

AU - Burisch, Johan

AU - Lophaven, Søren

AU - Langholz, Ebbe

AU - Munkholm, Pia

N1 - Publisher Copyright: © 2021 John Wiley & Sons Ltd

PY - 2022

Y1 - 2022

N2 - Background: Few population-based studies have investigated the long-term prognosis of Crohn's disease (CD). Aim: To determine the long-term natural disease course of CD with regard to surgery, cancer and mortality in a population-based cohort followed for more than 50 years. Methods: All patients diagnosed with CD from 1962 to 1987 in Copenhagen County, Denmark were included in a population-based cohort. Information about surgeries, cancers and mortality was collected from patient files from 1962 to 1987 and from the Danish National Patient Registry, Cancer Registry, and from the Register of Causes of Death, 1987-2017. Patients were matched with individuals from the general population. Results: A total of 373 patients were followed for a median of 33 years (range: 0-56 years). The cumulative probability of surgery 10, 20, 30, 40 and 50 years after diagnosis was 62% (CI 95%: 57%-67%), 71% (CI 95%: 66%-75%), 72% (CI 95%: 67%-76%), 74% (CI 95%: 69%-79%) and 74% (CI 95%: 69%-79%), respectively. A total of 142 patients (54%) were operated upon at least twice: 69 (26%) needing two surgeries and 73 (28%) needing three or more. Patients with CD were found to be at increased risk of intestinal (small bowel, rectum and anus) and extra-intestinal (respiratory organs and skin) cancer. All-cause mortality among CD patients was higher than among controls (RR: 1.22, CI 95%: 1.04-1.43), whereas mortality due to gastrointestinal cancer was not. Conclusion: After 50 years of follow-up, 75% CD patients had undergone surgery, with most needing repeat surgery. The risk of intestinal and extra-intestinal cancers, as well as mortality, was higher among CD patients than the background population.

AB - Background: Few population-based studies have investigated the long-term prognosis of Crohn's disease (CD). Aim: To determine the long-term natural disease course of CD with regard to surgery, cancer and mortality in a population-based cohort followed for more than 50 years. Methods: All patients diagnosed with CD from 1962 to 1987 in Copenhagen County, Denmark were included in a population-based cohort. Information about surgeries, cancers and mortality was collected from patient files from 1962 to 1987 and from the Danish National Patient Registry, Cancer Registry, and from the Register of Causes of Death, 1987-2017. Patients were matched with individuals from the general population. Results: A total of 373 patients were followed for a median of 33 years (range: 0-56 years). The cumulative probability of surgery 10, 20, 30, 40 and 50 years after diagnosis was 62% (CI 95%: 57%-67%), 71% (CI 95%: 66%-75%), 72% (CI 95%: 67%-76%), 74% (CI 95%: 69%-79%) and 74% (CI 95%: 69%-79%), respectively. A total of 142 patients (54%) were operated upon at least twice: 69 (26%) needing two surgeries and 73 (28%) needing three or more. Patients with CD were found to be at increased risk of intestinal (small bowel, rectum and anus) and extra-intestinal (respiratory organs and skin) cancer. All-cause mortality among CD patients was higher than among controls (RR: 1.22, CI 95%: 1.04-1.43), whereas mortality due to gastrointestinal cancer was not. Conclusion: After 50 years of follow-up, 75% CD patients had undergone surgery, with most needing repeat surgery. The risk of intestinal and extra-intestinal cancers, as well as mortality, was higher among CD patients than the background population.

U2 - 10.1111/apt.16615

DO - 10.1111/apt.16615

M3 - Journal article

C2 - 34543457

AN - SCOPUS:85115085865

VL - 55

SP - 73

EP - 82

JO - Alimentary Pharmacology and Therapeutics, Supplement

JF - Alimentary Pharmacology and Therapeutics, Supplement

SN - 0953-0673

IS - 1

ER -

ID: 280727306